The continuous bioprocessing market is expected to grow at a CAGR of 22.9% from 2020 to 2027 to reach $197.8 million by 2027. Continuous bioprocessing involves manufacturing biopharmaceuticals where continuous unit operations are physically connected with minimal ...
The Immunoassay Market is expected to reach $43.51 billion by 2027, at a CAGR of 8.0% during the forecast period of 2020 to 2027. The increasing prevalence of acute and chronic infectious diseases coupled with the rising geriatric population, growing awareness ...
The peripheral vascular devices market is expected to grow at a CAGR of 6.2% from 2020 to 2027 to reach $11.13 billion by 2027. Peripheral vascular diseases cause the narrowing or blockage of peripheral arteries and veins. Peripheral vascular devices are surgical ...
The infectious disease diagnostics market is expected to grow at a CAGR of 6.9% from 2020 to 2027 to reach at $42.85 billion by 2027. The epidemiological burden of infectious diseases like severe acute respiratory syndrome (SARS), Middle East respiratory syndrome ...
The mid-revenue cycle management/clinical documentation improvement market is expected to grow at a CAGR of 6.6% from 2020 to 2027 to reach $4.55 billion by 2027. Mid-revenue cycle management/clinical documentation improvement are the solutions utilized to attain ...
The chromatography consumables market is expected to grow at a CAGR of 6.0% from 2020 to 2027 to reach $3.64 billion by 2027. Chromatography is an analytical technique used in pharmaceutical, chemicals, food, and environmental testing laboratories to separate mixtures. ...
The pharmaceutical contract development and manufacturing market is expected to grow at a CAGR of 6.5% from 2020 to 2027 to reach $134.23 billion by 2027. The complex structure for manufacturing pharmaceuticals, increasing investments in pharmaceutical R&D, growing ...
The lateral flow assays (LFA) market is expected to grow at a CAGR of 8.8% from 2020 to 2027 to reach $13.85 billion by 2027. Lateral flow assay kits are used to rapidly test for infectious diseases, cardiac markers, pregnancy & fertility, cholesterol testing/lipid ...
The blood screening market is expected to grow at a CAGR of 6.9% from 2020 to 2027 to reach $3.56 billion by 2027. Blood screening is one of the most ideal and preferred tests for diagnosing various infectious diseases. Blood screening enables physicians to diagnose ...
The vaccine storage equipment market is expected to grow at a CAGR of 10.6% from 2020 to reach $1.83 billion by 2027. Vaccines are extremely sensitive in nature and require to be kept at recommended temperature to maintain its efficiency. Purpose-built storage ...
The urinalysis market is expected to grow at a CAGR of 4.5% from 2020 to 2027 to reach $2.19 billion by 2027. Urinalysis is an integral part of routine health check-up. This diagnostic method can also detect disease-specific biomarkers, chemical compounds, or ...
The sterilization equipment market is expected to grow at a CAGR of 12.2% from 2020 to 2027 to reach $23.7 billion by 2027. Sterilization is one of the key processes in many industries, including healthcare. In the healthcare sector, this process plays an important ...
The Real-World Evidence (RWE) Solutions market is projected to reach USD 3.13 billion by 2027 from USD 1.08 billion in 2020, at a CAGR of 16.5% during the forecast period. The growing geriatric population and burden of chronic diseases, shift towards value-based ...
The analytical standards market is expected to grow at a CAGR of 6.8% from 2020 to 2027 to reach $2.66 billion by 2027. An analytical standard is a compound of known concentration and high purity, used as a calibration standard for a given assay. The growth in ...
The sleep apnea devices market is expected to reach $12.9 billion by 2027, at a CAGR of 10.3% during the forecast period of 2020 to 2027. Large number of undiagnosed sleep apnea patients, increasing public and clinical awareness about sleep apnea with growing public ...